Rezolute, Inc. (RZLT) financial statements (2022 and earlier)

Company profile

Business Address 201 REDWOOD SHORES PARKWAY, SUITE 315
REDWOOD CITY, CA 94065
State of Incorp. DE
Fiscal Year End June 30
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments77,40341,0479,95511,5731,6464,4874,062
Cash and cash equivalents77,40341,0479,95511,5731,6464,4874,062
Other current assets    362442430
Other undisclosed current assets695946563571   
Total current assets:78,09841,99310,51812,1442,0084,9294,492
Noncurrent Assets
Operating lease, right-of-use asset237396383
Property, plant and equipment222933443685,3255,985
Intangible assets, net (including goodwill)   29374452
Intangible assets, net (excluding goodwill)   29374452
Deposits noncurrent assets    57244375
Restricted cash and investments5,000      
Deferred costs48191  3386 
Other undisclosed noncurrent assets  3135   
Total noncurrent assets:5,3076164471084955,7006,411
TOTAL ASSETS:83,40542,60910,96512,2522,50310,62910,903
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:5,8211,3541,2011,0511,7061,6531,501
Accounts payable4,3491,035893    
Accrued liabilities 242188    
Employee-related liabilities1,47277120790771  
Interest and dividends payable    148315
Other undisclosed accounts payable and accrued liabilities   2617871,6501,486
Debt   103,4351083
Derivative instruments and hedges, liabilities     112
Other liabilities47734918028114105120
Other undisclosed current liabilities1472651,8457,290993315
Total current liabilities:6,4451,9683,2268,3796,2481,7711,731
Noncurrent Liabilities
Long-term debt and lease obligation134187165    
Operating lease, liability134187165
Liabilities, other than long-term debt   121191305400
Other liabilities   121191305400
Other undisclosed noncurrent liabilities14,42714,168442,0002525 
Total noncurrent liabilities:14,69514,5423742,121216330400
Total liabilities:21,14016,5103,60010,5006,4642,1012,131
Stockholders' equity
Stockholders' equity attributable to parent62,26526,0997,3651,752(3,961)8,5288,773
Common stock1686210624935
Additional paid in capital250,816194,229154,595128,44590,16172,80152,783
Accumulated deficit(188,567)(168,138)(147,236)(126,903)(94,184)(64,322)(44,045)
Total stockholders' equity:62,26526,0997,3651,752(3,961)8,5288,773
TOTAL LIABILITIES AND EQUITY:83,40542,60910,96512,2522,50310,62910,903

Income statement (P&L) ($ in thousands)

12/31/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
Revenues
(Other Income)
13      
Cost of revenue
(Cost of Goods and Services Sold)
(457)(765)(882)(1,232)(1,162)(2,597)(2,415)
Gross profit:(444)(765)(882)(1,232)(1,162)(2,597)(2,415)
Operating expenses(31,908)(22,894)(20,521)(25,944)(28,734)(20,324)(14,951)
Other undisclosed operating income4447658821,2321,1622,5972,415
Operating loss:(31,908)(22,894)(20,521)(25,944)(28,734)(20,324)(14,951)
Nonoperating income (expense)(432)1,992188(4,502)(1,128)4716
Investment income, nonoperating161,789 2271644921
Debt instrument, convertible, beneficial conversion feature  2,233    
Interest and debt expense (375) (4,958)(602)(2)(5)
Other undisclosed loss from continuing operations before equity method investments, income taxes(375)      
Loss before gain (loss) on sale of properties:(32,715)(21,277)(20,333)(35,404)(30,464)(20,279)(14,941)
Other undisclosed net income313375     
Net loss:(32,402)(20,902)(20,333)(35,404)(30,464)(20,279)(14,941)
Net loss attributable to noncontrolling interest   (2,273)   
Other undisclosed net income attributable to parent1,788  7,23160225
Net loss attributable to parent:(30,614)(20,902)(20,333)(30,446)(29,862)(20,277)(14,936)
Preferred stock dividends and other adjustments      (5,974)
Other undisclosed net loss available to common stockholders, basic   (2,273) (3,407) 
Net loss available to common stockholders, diluted:(30,614)(20,902)(20,333)(32,719)(29,862)(23,684)(20,910)

Comprehensive Income ($ in thousands)

12/31/2021
TTM
6/30/2021
6/30/2020
6/30/2019
6/30/2018
6/30/2017
6/30/2016
Net loss:(32,402)(20,902)(20,333)(35,404)(30,464)(20,279)(14,941)
Comprehensive loss:(32,402)(20,902)(20,333)(35,404)(30,464)(20,279)(14,941)
Comprehensive loss, net of tax, attributable to noncontrolling interest   (2,273)   
Comprehensive loss, net of tax, attributable to parent:(32,402)(20,902)(20,333)(37,677)(30,464)(20,279)(14,941)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: